<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Nutr</journal-id><journal-id journal-id-type="publisher-id">BJN</journal-id><journal-title-group><journal-title>The British Journal of Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0007-1145</issn><issn pub-type="epub">1475-2662</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26328470</article-id><article-id pub-id-type="pmc">4594049</article-id><article-id pub-id-type="doi">10.1017/S0007114515002950</article-id><article-id pub-id-type="pii">S0007114515002950</article-id><article-id pub-id-type="publisher-id">00295</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Papers</subject></subj-group><subj-group subj-group-type="section"><subject>Human and Clinical Nutrition</subject></subj-group></article-categories><title-group><article-title>Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood
pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension:
a randomised double-blinded placebo-controlled cross-over trial</article-title><alt-title alt-title-type="left-running">V. Br&#x000fc;ll <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">Effects of quercetin on blood pressure</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Br&#x000fc;ll</surname><given-names>Verena</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Burak</surname><given-names>Constanze</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stoffel-Wagner</surname><given-names>Birgit</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wolffram</surname><given-names>Siegfried</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nickenig</surname><given-names>Georg</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Cornelius</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Langguth</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Alteheld</surname><given-names>Birgit</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fimmers</surname><given-names>Rolf</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Naaf</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Zimmermann</surname><given-names>Benno F.</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Stehle</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Egert</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Nutrition and Food Sciences</addr-line>, <addr-line>Nutritional
Physiology</addr-line>, <institution>University of Bonn</institution>, <addr-line>53115
Bonn</addr-line>, <country>Germany</country></aff><aff id="aff2"><label>2</label><addr-line>Institute of Clinical Chemistry and Clinical Pharmacology</addr-line>,
<institution>University Hospital Bonn</institution>, <addr-line>53127 Bonn</addr-line>,
<country>Germany</country></aff><aff id="aff3"><label>3</label><addr-line>Institute of Animal Nutrition and Physiology</addr-line>,
<institution>Christian-Albrechts-University Kiel</institution>, <addr-line>24118
Kiel</addr-line>, <country>Germany</country></aff><aff id="aff4"><label>4</label><addr-line>Department of Cardiology</addr-line>, <addr-line>Angiology and
Pneumology</addr-line>, <institution>University Hospital Bonn</institution>,
<addr-line>53127 Bonn</addr-line>, <country>Germany</country></aff><aff id="aff5"><label>5</label><addr-line>Department of Biopharmaceutics and Pharmaceutical Technology</addr-line>,
<addr-line>Institute of Pharmacy and Biochemistry</addr-line>, <institution>Johannes
Gutenberg University Mainz</institution>, <addr-line>55099 Mainz</addr-line>,
<country>Germany</country></aff><aff id="aff6"><label>6</label><addr-line>Institute of Medical Biometry</addr-line>, <addr-line>Informatics and
Epidemiology</addr-line>, <institution>University Hospital Bonn</institution>,
<addr-line>53127 Bonn</addr-line>, <country>Germany</country></aff><aff id="aff7"><label>7</label> Institut Prof. Dr. Georg Kurz GmbH, <addr-line>50933 K&#x000f6;ln</addr-line>,
<country>Germany</country></aff><aff id="aff8"><label>8</label><addr-line>Department of Nutrition and Food Sciences</addr-line>, <addr-line>Food Technology
and Biotechnology</addr-line>, <institution>University of Bonn</institution>,
<addr-line>53117 Bonn</addr-line>, <country>Germany</country></aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> S. Egert, fax +<fax>49 228 733217</fax>, email <email>s.egert@uni-bonn.de</email></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>28</day><month>10</month><year>2015</year></pub-date><volume>114</volume><issue>8</issue><fpage>1263</fpage><lpage>1277</lpage><history><date date-type="received"><day>11</day><month>3</month><year>2015</year></date><date date-type="rev-recd"><day>25</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>07</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Authors 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>The Authors</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits
unrestricted re-use, distribution, and reproduction in any medium, provided the original
work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0007114515002950a.pdf"/><abstract abstract-type="normal"><p>The polyphenol quercetin may prevent CVD due to its antihypertensive and vasorelaxant
properties. We investigated the effects of quercetin after regular intake on blood
pressure (BP) in overweight-to-obese patients with pre-hypertension and stage I
hypertension. In addition, the potential mechanisms responsible for the hypothesised
effect of quercetin on BP were explored. Subjects (<italic>n</italic> 70) were randomised
to receive 162 mg/d quercetin from onion skin extract powder or placebo in a
double-blinded, placebo-controlled cross-over trial with 6-week treatment periods
separated by a 6-week washout period. Before and after the intervention, ambulatory blood
pressure (ABP) and office BP were measured; urine and blood samples were collected; and
endothelial function was measured by EndoPAT technology. In the total group, quercetin did
not significantly affect 24 h ABP parameters and office BP. In the subgroup of
hypertensives, quercetin decreased 24 h systolic BP by &#x02212;3&#x000b7;6 mmHg
(<italic>P</italic>=0&#x000b7;022) when compared with placebo (mean treatment difference, &#x02212;3&#x000b7;9
mmHg; <italic>P</italic>=0&#x000b7;049). In addition, quercetin significantly decreased day-time
and night-time systolic BP in hypertensives, but without a significant effect in
inter-group comparison. In the total group and also in the subgroup of hypertensives,
vasoactive biomarkers including endothelin-1, soluble endothelial-derived adhesion
molecules, asymmetric dimethylarginine, angiotensin-converting enzyme activity,
endothelial function, parameters of oxidation, inflammation, lipid and glucose metabolism
were not affected by quercetin. In conclusion, supplementation with 162 mg/d quercetin
from onion skin extract lowers ABP in patients with hypertension, suggesting a
cardioprotective effect of quercetin. The mechanisms responsible for the BP-lowering
effect remain unclear.</p></abstract><kwd-group><title>Key words</title><kwd>Quercetin</kwd><kwd>Blood pressure</kwd><kwd>Endothelial function</kwd><kwd>Hypertension</kwd><kwd>Cardiovascular diseases</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><compound-kwd><compound-kwd-part content-type="abbrev">ABP</compound-kwd-part><compound-kwd-part content-type="expansion">ambulatory blood pressure</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">ACE</compound-kwd-part><compound-kwd-part content-type="expansion">angiotensin-converting
enzyme</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">ADMA</compound-kwd-part><compound-kwd-part content-type="expansion">asymmetric
dimethylarginine</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">BP</compound-kwd-part><compound-kwd-part content-type="expansion">blood pressure</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">DBP</compound-kwd-part><compound-kwd-part content-type="expansion">diastolic blood pressure</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">IsoP</compound-kwd-part><compound-kwd-part content-type="expansion">isoprostanes</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">MAP</compound-kwd-part><compound-kwd-part content-type="expansion">mean arterial pressure</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">oxLDL</compound-kwd-part><compound-kwd-part content-type="expansion">oxidised LDL</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">PAT</compound-kwd-part><compound-kwd-part content-type="expansion">peripheral arterial
tonometry</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">RHI</compound-kwd-part><compound-kwd-part content-type="expansion">reactive hyperaemia index</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">SBP</compound-kwd-part><compound-kwd-part content-type="expansion">systolic blood pressure</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">sICAM-1</compound-kwd-part><compound-kwd-part content-type="expansion">soluble intercellular adhesion molecule
1</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">sVCAM-1</compound-kwd-part><compound-kwd-part content-type="expansion">soluble vascular cell adhesion molecule
1</compound-kwd-part></compound-kwd></kwd-group><counts><fig-count count="2"/><table-count count="6"/><page-count count="15"/></counts></article-meta></front><body><p>Quercetin (3,3&#x02032;,4&#x02032;,5,7-pentahydroxyflavone) is one of the predominant flavonoids,
ubiquitously distributed in (edible) plants, and one of the most potent antioxidants of plant
origin<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>. Rich sources of dietary quercetin are onions, kale, unpeeled apples, berries,
citrus fruits and tea (<italic>Camellia sinensis</italic>). In Western populations, crude
estimates of mean dietary intake appear to be 10&#x02013;30 mg/d<xref rid="ref2" ref-type="bibr">
<sup>(2</sup>
</xref>
<sup>,</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>. As demonstrated in cohort studies, dietary intake of flavonoids in general and
of quercetin in particular is associated with a decreased risk for CVD<sup>(</sup>
<xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>. Although the physiological mechanisms accounting for this benefit remain
incompletely defined, animal studies and human intervention studies have identified many
relevant effects &#x02013; for example, supplementation of quercetin may reduce platelet
aggregation<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>,</sup>
<xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> and plasma concentrations of atherogenic oxidised LDL (oxLDL)<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. <italic>In vitro</italic> studies suggest that high concentrations of quercetin
(&#x0003e;1 &#x000b5;<sc>m</sc>) have anti-inflammatory effects<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>. Studies in animal models (e.g. obese Zucker rats) suggest beneficial effects of
quercetin on obesity-associated metabolic disorders including insulin resistance and
dyslipidaemia<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>)</sup>. We recently showed that in patients with high CVD risk phenotype, chronic
supplementation with a supra-nutritional dose of 150 mg/d quercetin significantly reduced
systolic blood pressure (SBP)<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. Similar findings have been reported by Edwards <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>)</sup> in hypertensive patients and, recently, by Zahedi <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup> in women with type 2 diabetes mellitus, although with pharmacological quercetin
doses (500 and 730 mg/d). Although several pathways have been suggested, the mechanisms by
which quercetin possibly affects blood pressure (BP) are not well-understood. These pathways
include (i) improvement of vascular function in an endothelium-dependent or
endothelium-independent manner, (ii) decrease in oxidative stress and/or (iii) interference
with the renin&#x02013;angiotensin&#x02013;aldosterone system<sup>(</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup>.</p><p>One limitation in the interpretation of the BP-lowering effect of chronic quercetin
supplementation is that all human studies published to date, including our own trial<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>, only measured the office (clinic) BP in the resting state (typically in the
morning while fasting) and did not integrate an ambulatory blood pressure (ABP) monitoring.
ABP monitoring is considered the gold standard for BP measurement, compared with clinic BP
measurements, as it is superior in terms of reliability and validity<sup>(</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>,</sup>
<xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup>. The superior predictive power of ABP monitoring is probably not only due to its
higher number of readings, which increases the reliability of the measurement, but also due to
its ability to capture the impact of stressors and other environmental factors that occur in
daily life and are likely to affect BP<sup>(</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>)</sup>. To the best of our knowledge, no previous study has examined the effects of
quercetin on 24 h ABP profiles thus far. Therefore, the aim of the present double-blinded,
placebo-controlled cross-over trial was to systematically investigate the effects of quercetin
on arterial BP (office BP and 24 h ABP profiles) in adults with pre-hypertension and stage I
hypertension, and to explore mechanisms involved in the BP-lowering efficacy of quercetin.
Furthermore, effects of quercetin on lipid and glucose metabolism were investigated.</p><sec sec-type="methods" id="sec1"><title>Methods</title><sec id="sec1-1" sec-type="general"><title>Subjects</title><p>Overweight-to-obese subjects were recruited from the community of the city of Bonn,
Germany, via public postings, flyers and advertisements in the local newspaper. From a
total of 500 interested subjects, 154 individuals aged 25&#x02013;65 years with a BMI of 25&#x02013;35
kg/m<sup>2</sup> attended a screening, which included physical assessments (body height
and weight, resting BP, heart rate, waist and hip circumference), clinical assessments
(liver function, serum lipids and lipoproteins, glucose and uric acid, haematology,
high-sensitive C-reactive protein (hs-CRP)), medical history and a dietary questionnaire.</p><p>Participants were included if they had the following traits of the metabolic syndrome:
(i) central obesity (waist circumference &#x02265;94 cm for men and &#x02265;80 cm for women); (ii)
pre-hypertension (&#x02265;120&#x02013;139 mmHg SBP and/or &#x02265;80&#x02013;89 mmHg diastolic blood pressure (DBP)) or
stage I hypertension (&#x02265;140&#x02013;159 mmHg SBP and/or &#x02265;90&#x02013;99 mmHg DBP); (iii) dyslipidaemia
(fasting serum TAG concentrations &#x02265;1&#x000b7;7 mmol/l and/or serum concentrations of
HDL-cholesterol &#x0003c;1&#x000b7;0 mmol/l for men and &#x0003c;1&#x000b7;3 mmol/l for women) and/or a
proinflammatory state (hs-CRP&#x02265;2 mg/l)<sup>(</sup>
<xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>,</sup>
<xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>)</sup>. Main exclusion criteria were as follows: smoking, diagnosed type 2 diabetes
mellitus, liver, gastrointestinal or diagnosed inflammatory diseases, a history of
cardiovascular events, untreated thyroid dysfunction, cancer, recent major surgery or
illness, pregnancy or breast feeding, alcohol abuse, consumption of polyphenol-rich
supplements, participation in a weight loss programme and Raynaud&#x02019;s syndrome.</p><p>A total of seventy subjects (thirty-five male, thirty-five female) were included into the
study. During the first intervention period, two subjects dropped out for personal
reasons. Only data from the remaining sixty-eight subjects (thirty-four male, thirty-four
female), who completed the entire intervention study, were included in the analysis and
are subsequently reported. The participant flow from the initial screening to final
analysis is shown in <xref ref-type="fig" rid="fig1">Fig. 1</xref>.<fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram of participants. ABP, ambulatory blood pressure; BP, blood
pressure.</p></caption><graphic xlink:href="S0007114515002950_fig1"/></fig>
</p><p>The study protocol was explained in detail to all the participants, who gave their
written informed consent at the beginning of the study. The study protocol was approved by
the ethics committee of the Medical Faculty of the Rheinische
Friedrich-Wilhelms-Universit&#x000e4;t Bonn, Germany, and was in accordance with the Helsinki
declaration. The trial was registered at <uri xlink:type="simple" xlink:href="http://www.germanctr.de">www.germanctr.de</uri>/ and <uri xlink:type="simple" xlink:href="http://apps.who.int/trialsearch/">http://apps.who.int/trialsearch/</uri> as DRKS00000555.</p><p>The subjects were instructed to maintain their habitual diet, physical activity levels,
lifestyle factors and body weight. Participants taking oral contraceptives
(<italic>n</italic> 4 women) or antihypertensive (<italic>n</italic> 12) or thyroid drugs
(<italic>n</italic> 9) were instructed to continue taking their medication without
changes.</p></sec><sec id="sec1-2" sec-type="general"><title>Study design</title><p>This study was a double-blinded, randomised, placebo-controlled cross-over trial with
6-week treatment periods separated by a 6-week washout period. Subjects were instructed to
take a total of three capsules per d, one capsule with each principal meal. Two kinds of
hard gelatin capsules &#x02013; quercetin and placebo &#x02013; were manufactured at the Institute of
Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz. Quercetin capsules were
filled with onion skin extract powder (132 mg/capsule); placebo capsules contained
mannitol (approximately 170 mg/capsule). For the production of the onion skin extract
powder, onion skins were washed with water and then extracted using ethanol. Thereafter,
the extraction solvent was removed by evaporation. The resulting suspension was decanted
and subsequently vacuum-dried. The flavonoid contents of the onion skin extract and of
quercetin capsules were determined by HPLC with diode-array detection. The identity of the
flavonoids was confirmed by MS/MS. The results of quantification are shown in <xref ref-type="table" rid="tab1">Table 1</xref>. The quercetin content of the onion skin
extract powder (<italic>Allium cepa</italic> L.; Rudolf Wild GmbH &#x00026; Company KG)
was 41&#x000b7;25 % (dry mass 95&#x000b7;94 %). Each quercetin capsule contained 54 mg quercetin. Hard
gelatin capsules (Coni-Snap<sup>&#x000ae;</sup>) size 0 were supplied by Capsugel. Quercetin and
placebo capsules were identical in shape and taste. Capsule filling was carried out using
a Dott Bonapace semi-automatic capsule filling machine. Mannitol was obtained from Fagron.
Quality was checked by determining the homogeneity of weight distributions of a sample of
twenty randomised capsules taken from each batch. Furthermore, the microbiological burden
of the capsules was determined following manufacture and before release. Primary packaging
was into blister packages. The primary investigators, all study personnel, and all the
participants were blinded to the treatments. A quercetin dosage of 162 mg per d (three
capsules) was selected to represent the 10- to 15-fold of the estimated mean daily
quercetin intake in Germany<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup> and other European populations<sup>(</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. Plasma kinetics of this quercetin dosage after bolus intake was examined
previously<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>,</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>.<table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Flavonoid analysis in onion skin extract powder<xref ref-type="fn" rid="tab1fn1">*</xref> (Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">% (g/100 g)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Compound</td><td align="center" rowspan="1" colspan="1">Mean</td><td align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Quercetin</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">44&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td></tr><tr><td align="left" rowspan="1" colspan="1">Quercetin dihexoside</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;04523</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;00027</td></tr><tr><td align="left" rowspan="1" colspan="1">Quercetin hexoside 1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;1557</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;0072</td></tr><tr><td align="left" rowspan="1" colspan="1">Quercetin hexoside 2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;79</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;017</td></tr><tr><td align="left" rowspan="1" colspan="1">Methylquercetin hexoside</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;0481</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;00030</td></tr><tr><td align="left" rowspan="1" colspan="1">Kaempferol</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;122</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;0017</td></tr><tr><td align="left" rowspan="1" colspan="1">Methylquercetin</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;0740</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;00033</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tab1fn1"><label>*</label><p>Analyses were conducted in duplicate.</p></fn></table-wrap-foot></table-wrap>
</p><p>Subjects were assigned to quercetin or placebo treatment according to a block-wise
randomisation scheme. Separate computer-generated randomisation schedules for men and
women were created to stratify subjects by sex with an attempt to achieve a distribution
between men and women of 50:50 in each treatment group. Randomisation, allocation to
either one of the capsules and capsule handling were carried out by an independent
researcher (B. A.). Capsules were handed out on days 0 and 21 of each treatment period
with a surplus of 20 %. Leftovers and empty blisters were collected on days 21 and 42.
Compliance was monitored by determining quercetin plasma concentrations after the
treatment periods (see below), by counting capsules at the end of the study and by
instructing subjects to document capsule consumption, potential observed side-effects,
deviations from their normal physical activity and any other observations considered
relevant in a study diary.</p><p>Subjects were instructed to keep 3-d food records at the beginning and at the end of each
treatment period. Each record represented the food and beverage intake of 2 weekdays and 1
weekend day. These dietary records were used to calculate the habitual dietary intake of
energy, nutrients and quercetin.</p><p>Sample size was calculated based on office BP data from our previous trial<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>,</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup> and expected changes in SBP. The calculation revealed that forty-nine
subjects had to complete the study to reach a 90 % power with a significance level of 0&#x000b7;01
to detect a 3 mmHg difference in BP between the quercetin and placebo groups (<sc>sd</sc>
of the within-subject was different from the SBP, 3&#x000b7;8 mmHg). With the assumption of a 30 %
dropout rate, we aimed to randomly assign approximately seventy participants.</p><p>The measurements of 24 h ABP, office BP, heart rate, vascular testing and anthropometric
measurements were conducted at the beginning and at the end of the two intervention
periods.</p></sec><sec id="sec1-3" sec-type="general"><title>Measurements</title><sec id="sec1-3-1" sec-type="general"><title>Office blood pressure and heart rate</title><p>Measurements of office BP and heart rate were obtained using an automatic BP
measurement device (boso carat professional, Bosch+Sohn) under standardised conditions
according to the recommendations of the American Heart Association Council on High Blood
Pressure Research<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>)</sup>. Each participant sat quietly for 5&#x02013;10 min, after which their arm was
placed at heart level and SBP and DBP were measured at least twice in 3- to 5-min
intervals. If BP measurements varied by 10 mmHg, an additional measurement was
performed. The accumulated measurements were then averaged to determine overall SBP and
DBP. The mean arterial pressure (MAP) was calculated as follows: (DBP+1/3
(SBP&#x02212;DBP)).</p></sec><sec id="sec1-3-2" sec-type="general"><title>24 h ambulatory blood pressure monitoring</title><p>The 24 h ABP and heart rate recordings were taken every 15 min between 06.00 and 22.00
hours (day-time) and every 30 min between 22.00 and 06.00 hours (night-time) using an
ABP monitor (Spacelabs monitor type 90207) on the non-dominant arm. On the day of
measurement, subjects were instructed to maintain their habitual activity level and to
refrain from strenuous exercise. We assessed the following BP parameters: 24 h, day-time
and night-time SBP, DBP, MAP, heart rate and the nocturnal dip in SBP and DBP.</p></sec><sec id="sec1-3-3" sec-type="general"><title>Vascular testing</title><p>For vascular testing, we used the noninvasive peripheral arterial tonometry (PAT)
technology to assess the reactive hyperaemia index (RHI) and the augmentation index (AI)
using the EndoPAT plethysmographic device (Endo-PAT2000). Details have been described
elsewhere<sup>(</sup>
<xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>. In brief, the PAT signal indicates changes of the peripheral arterial tone
in peripheral arterial beds by recording the arterial pulsatile volume changes from the
fingertip. For that purpose, we placed a pair of plethysmographic biosensors on both
index fingers and a BP cuff on the upper arm of the study arm (left arm), whereas the
right arm served as the control arm (without a cuff). The recording of the PAT signal
started after a resting period of at least 15 min with a 1 min standby-test period. If
the signal recording was free from interferences, the test period started with a 5 min
baseline recording of the pulse wave amplitude. Subsequently, the BP cuff was inflated
for 5 min to supra-systolic values to induce ischaemia whereupon the cuff was deflated.
This resulted in reactive hyperaemia while further recording for 5 min. PAT signals were
analysed with automated software (Itamar Medical), and RHI was calculated as the ratio
of the average PAT signal amplitude over a 1 min period starting 1 min after
cuff-deflation divided by the average PAT signal amplitude over a 3&#x000b7;5 min period at the
baseline recording followed by normalisation of the values from the study arm to the
control arm. The RHI correlates with brachial artery flow-mediated dilatation<sup>(</sup>
<xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup> and is significantly influenced by nitric oxide (NO)<sup>(</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>. A lower RHI was found in subjects with coronary endothelial
dysfunction<sup>(</sup>
<xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup> and in the presence of CVD risk factors<sup>(</sup>
<xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-3-4" sec-type="general"><title>Anthropometrics</title><p>Body height was determined on a stadiometer to the nearest 0&#x000b7;1 cm. Body weight was
determined to the nearest 100 g. Waist circumference was measured midway between the
lowest rib and the ilial crest, while the subject was at minimal respiration. Hip
circumference was measured at the height of trochanteres majores. Body composition was
measured by bioelectrical impedance analysis (Nutrigard-M, Multi Frequency
Phase-Sensitive Bioelectrical Impedance Analyzer, Data Input). Fat-free mass (FFM) was
calculated in accordance with Sun <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref>
<sup>)</sup>; fat mass was calculated by subtracting FFM from body weight.</p></sec></sec><sec id="sec1-4" sec-type="general"><title>Blood/urine sample processing and analysis</title><p>Fasting venous blood samples were collected on the first and the last visit of each
intervention period between 06.30 and 09.00 hours under standardised conditions. The
subjects were instructed to abstain for 24 h from alcoholic beverages and were told not to
engage in strenuous exercise on the day before blood sampling. The last capsule was taken
in the evening before blood sampling. Blood was drawn into tubes containing EDTA, lithium
heparin, fluoride or a coagulation activator (Sarstedt). Plasma/serum was obtained by
centrifugation at 3000 <italic><bold>g</bold></italic> for 15 min at 8&#x000b0;C. Plasma/serum aliquots were immediately frozen in cryovials
and stored at &#x02212;80&#x000b0;C until analysis. All the laboratory measurements were performed without
knowledge of the treatment. All serum and plasma samples of one subject were analysed in
the same assay run.</p><p>Serum concentration of total cholesterol was measured using polychromatic
endpoint-measurement, whereas serum concentrations of LDL-cholesterol, HDL-cholesterol,
TAG and plasma concentrations of glucose were measured using bichromatic
endpoint-measurement with a Dimension Vista 1500 analyser (Siemens Healthcare
Diagnostics). Serum concentrations of apo B, A1 and hs-CRP were determined using
nephelometric methods with a Dimension Vista 1500 analyser.</p><p>Serum insulin concentration was measured using a chemiluminescent&#x02013;immunometric assay with
the Immulite 2000 analyser (Siemens Healthcare Diagnostics). Insulin resistance was
measured using the homoeostatic model assessment (HOMA) and calculated as the product of
the fasting plasma insulin concentration (in &#x003bc;U/ml) and the fasting plasma glucose
concentration (in mmol/l), divided by 22&#x000b7;5<sup>(</sup>
<xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref>
<sup>)</sup>. HbA<sub>1c</sub> was measured using an HPLC-method with a Variant II
analyser (Bio-Rad Laboratories). Serum concentrations of angiotensin-converting enzyme
(ACE) were measured using a photometric method (Buehlmann Laboratories) with a Dimension
Vista 1500 analyser.</p><p>Plasma ADMA (Immundiagnostik), plasma oxLDL (Immundiagnostik), serum endothelin-1 and
serum-soluble adhesion molecules E-selectin, soluble intercellular adhesion molecule 1
(sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1) (R&#x00026;D systems)
were determined in duplicate using commercially available enzyme-linked immunoassay kits
according to the manufacturer&#x02019;s instructions and quality controls. Plasma concentration of
<sc>l</sc>-arginine was determined using reversed-phase HPLC as described
previously<sup>(</sup>
<xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref>
<sup>)</sup>.</p><p>Analyses of plasma concentrations of quercetin, its monomethylated derivatives
tamarixetin (4&#x02032;-<italic>O</italic>-methyl quercetin) and isorhamnetin
(3&#x02032;-<italic>O</italic>-methyl quercetin) as well as of the dehydroxylated quercetin
metabolite kaempferol were carried out using HPLC with fluorescence detection as described
previously<sup>(</sup>
<xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref>
<sup>)</sup>. All the samples were treated enzymatically with
<italic>&#x003b2;</italic>-glucuronidase/sulphatase before the extraction of the flavonols. Total
plasma flavonols were calculated as follows: total flavonols (nmol/l)=quercetin
(nmol/l)+kaempferol (nmol/l)+isorhamnetin (nmol/l)+tamarixetin (nmol/l).</p><p>First morning urine samples were collected on the first and the last visit of the
intervention periods, 0&#x000b7;002 % of butylated hydroxytoluene was added and the urine was
frozen at &#x02212;80 &#x000b0;C until analysis. From these urine samples, 8-iso-PG F2<italic>&#x003b1;</italic>
(8-iso-PGF2<italic>&#x003b1;</italic>) and 2,3-dinor-15-F2t-IsoP were measured by UHPLC-MS/MS.
Urinary creatinine levels were determined using a bichromatic kinetic method (Jaff&#x000e9;
method).</p></sec><sec id="sec1-5" sec-type="general"><title>Self-reported dietary intake of energy, nutrients and quercetin</title><p>The self-reported intakes of energy, macronutrients, dietary fibre and antioxidant
pro-vitamins/vitamins were calculated using the computer-based nutrient calculation
programme EBISpro (University of Hohenheim) based on the German Nutrient Database
Bundeslebensmittelschl&#x000fc;ssel (Max Rubner-Institute). The quercetin intake was estimated
using the USDA flavonoid database<sup>(</sup>
<xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-6" sec-type="general"><title>Statistical analyses</title><p>All the statistical analyses were performed using IBM SPSS statistical software package
(version 20). Differences between sexes at screening were tested using the unpaired
Student&#x02019;s <italic>t</italic> test or the Mann&#x02013;Whitney <italic>U</italic> test. Baseline
values were compared between groups using paired Student&#x02019;s <italic>t</italic> tests or
Wilcoxon signed-rank tests. Intra-group (baseline <italic>v.</italic> endpoint) and
inter-group comparisons (changes during quercetin <italic>v.</italic> changes during
placebo treatment) of normally distributed data were performed using paired Student&#x02019;s
<italic>t</italic> tests. Intra-group and inter-group comparisons of data that were not
normally distributed, which was mainly the case for serum TAG, plasma glucose, serum
insulin, HOMA IR index, plasma oxLDL, serum hs-CRP and urinary IsoP, were conducted by
Wilcoxon signed-rank tests (for details, see footnotes in Tables).</p><p>Interaction effects between the stage of hypertension and treatment assignment were
tested using a univariate ANOVA with the respective variables as fixed factors. In all
cases, a value for <italic>P</italic>&#x02264;0&#x000b7;05 (two-sided) was taken to indicate significant
effects. Pearson&#x02019;s correlation coefficient was used to assess relationships between BP
variables (SBP and DBP) and biomarkers of inflammation/endothelial function and also
between BP variables and plasma flavonols. A test for carry-over effects according to
Kenward and Jones<sup>(</sup>
<xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref>
<sup>)</sup> was used. No carry-over effects between the two treatment periods could be
observed. All the analyses are presented on a per-protocol basis. For all sixty-eight
participants, complete data sets were available.</p><p>All data were analysed for the whole study group (<italic>n</italic> 68) and also for the
subgroup of patients with hypertension. Office BP data were classified according to
Chobanian <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>)</sup>. Classification of ABP data was conducted as described by Pickering
<italic>et al.</italic>
<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>)</sup> (for details see footnotes in <xref ref-type="table" rid="tab4">Table
4</xref>).<table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Measurements of the 24 h ambulatory blood pressure and office blood pressure in the
subgroup of hypertensive patients during the 6-week dietary supplementation with
quercetin or placebo<xref ref-type="fn" rid="tab4fn1">*</xref> (Mean values and
standard deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab4"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="7">Quercetin</th><th align="center" rowspan="1" colspan="8">Placebo</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> inter-group</th><th align="center" rowspan="1" colspan="2">Treatment difference</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">24 h ABP monitoring<xref ref-type="fn" rid="tab4fn2">&#x02020;</xref>
</td><td align="center" rowspan="1" colspan="7">(<italic>n</italic> 31)</td><td align="center" rowspan="1" colspan="8">(<italic>n</italic> 29)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">141&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">137&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td><td align="left" rowspan="1" colspan="1">0&#x000b7;022</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">139&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">140&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;690</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;049</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">88&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">86&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;2</td><td align="left" rowspan="1" colspan="1">0&#x000b7;074</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">86&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">86&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;680</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;124</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">106&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">103&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="left" rowspan="1" colspan="1">0&#x000b7;043</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">104&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">104&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;710</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;151</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">76&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">77&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;5</td><td align="left" rowspan="1" colspan="1">0&#x000b7;081</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">76&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">77&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;445</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;435</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td></tr><tr><td align="left" rowspan="1" colspan="1"> Nocturnal dip in systolic BP (%)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;4</td><td align="left" rowspan="1" colspan="1">0&#x000b7;758</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;035</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;142</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1"> Nocturnal dip in diastolic BP (%)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;8</td><td align="left" rowspan="1" colspan="1">0&#x000b7;477</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">13&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+3&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;051</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;213</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Day-time (06.00&#x02013;22.00 hours)<xref ref-type="fn" rid="tab4fn3">&#x02021;</xref>
</td><td align="center" rowspan="1" colspan="7">(<italic>n</italic> 27)</td><td align="center" rowspan="1" colspan="8">(<italic>n</italic> 23)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">146&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">141&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;4&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td><td align="left" rowspan="1" colspan="1">0&#x000b7;014</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">144&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">144&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;964</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;109</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;4&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">92&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">90&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;9</td><td align="left" rowspan="1" colspan="1">0&#x000b7;070</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">90&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">90&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;399</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;111</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">110&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">107&#x000b7;54</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="left" rowspan="1" colspan="1">0&#x000b7;042</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">108&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">108&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;644</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;110</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;4&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">79&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">80&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;3</td><td align="left" rowspan="1" colspan="1">0&#x000b7;211</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">79&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">80&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;311</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;793</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1">Night-time (22.00&#x02013;06.00 hours)<xref ref-type="fn" rid="tab4fn4">&#x000a7;</xref>
</td><td align="center" rowspan="1" colspan="7">(<italic>n</italic> 21)</td><td align="center" rowspan="1" colspan="8">(<italic>n</italic> 27)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">134&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">128&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;9</td><td align="left" rowspan="1" colspan="1">0&#x000b7;007</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">131&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">126&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;5&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;021</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;667</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">18&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">80&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">75&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;4&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;2</td><td align="left" rowspan="1" colspan="1">0&#x000b7;006</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">78&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">75&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;045</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;289</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">93&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;3</td><td align="left" rowspan="1" colspan="1">0&#x000b7;001</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">96&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">92&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;037</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;345</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;3&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;4</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">68&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">71&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;3</td><td align="left" rowspan="1" colspan="1">0&#x000b7;049</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">69&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">67&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;235</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;127</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+4&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1">Office BP<xref ref-type="fn" rid="tab4fn5">&#x02016;</xref>
</td><td align="center" rowspan="1" colspan="7">(<italic>n</italic> 59)</td><td align="center" rowspan="1" colspan="8">(<italic>n</italic> 55)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">147&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">149&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;9</td><td align="left" rowspan="1" colspan="1">0&#x000b7;131</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">147&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">147&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;685</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;311</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">100&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="left" rowspan="1" colspan="1">0&#x000b7;138</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">100&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;072</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;972</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;4</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">115&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">115&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="left" rowspan="1" colspan="1">0&#x000b7;718</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">116&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">114&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;186</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;676</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">65&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">65&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;5</td><td align="left" rowspan="1" colspan="1">0&#x000b7;256</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">64&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">65&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;109</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;575</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>ABP, Ambulatory blood pressure; BP, blood pressure; MAP, mean arterial
pressure.</p></fn><fn id="tab4fn1"><label>*</label><p>The two groups did not differ significantly with regard to any of the variables
at baseline (paired Student&#x02019;s <italic>t</italic> tests or Wilcoxon signed-rank
tests). All the subjects participated in both treatments. There are different n
values for quercetin and placebo treatment because the initial blood pressure of
the participants at the beginning of the quercetin and placebo treatment period
slightly differed. In some cases, this physiological difference led to a different
blood pressure classification.</p></fn><fn id="tab4fn2"><label>&#x02020;</label><p>Systolic BP&#x0003e;135 and/or diastolic BP&#x0003e;85 mmHg (according to reference
25).</p></fn><fn id="tab4fn3"><label>&#x02021;</label><p>Systolic BP&#x0003e;140 and/or diastolic BP&#x0003e;90 mmHg (according to reference
25).</p></fn><fn id="tab4fn4"><label>&#x000a7;</label><p>Systolic BP&#x0003e;125 and/or diastolic BP&#x0003e;75 mmHg (according to reference
25).</p></fn><fn id="tab4fn5"><label>&#x02016;</label><p>Stage 1 hypertensive: systolic BP&#x02265;140 and/or diastolic BP&#x02265;90 mmHg (according to
reference 18).</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="general" id="sec2"><title>Results</title><sec id="sec2-1" sec-type="general"><title>Subject characteristics at screening, compliance and dietary intake</title><p>Characteristics of the participants at screening are presented in <xref ref-type="table" rid="tab2">Table 2</xref>. As planned, all subjects were overweight (43 %) or obese (57
%), had a visceral fat distribution and were pre-hypertensive or stage 1 hypertensive. We
observed sex differences with respect to body height, body weight, waist and hip
circumference, waist:hip ratio and fasting serum concentrations of TAG, total cholesterol,
HDL-cholesterol and plasma glucose (<xref ref-type="table" rid="tab2">Table
2</xref>).<table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Subject characteristics and blood parameters at screening (Mean values and standard
deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Total (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="2">Women (<italic>n</italic> 34)</th><th align="center" rowspan="1" colspan="2">Men (<italic>n</italic> 34)</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Women <italic>v.</italic> men
(<italic>P</italic>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">47&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">48&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">46&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;396</td></tr><tr><td align="left" rowspan="1" colspan="1">Body height (cm)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">173&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">168&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">179&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">94&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">88&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">15&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;021</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">31&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">31&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">31&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;677</td></tr><tr><td align="left" rowspan="1" colspan="1">Overweight (%)</td><td align="center" rowspan="1" colspan="2">43</td><td align="center" rowspan="1" colspan="2">50</td><td align="center" rowspan="1" colspan="2">35</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Obese (%)</td><td align="center" rowspan="1" colspan="2">57</td><td align="center" rowspan="1" colspan="2">50</td><td align="center" rowspan="1" colspan="2">65</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">103&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">108&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;008</td></tr><tr><td align="left" rowspan="1" colspan="1">Hip circumference (cm)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">111&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">115&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">107&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;001</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist:hip ratio</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;93</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;86</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">144&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">141&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">13&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">147&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;077</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">94&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">94&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">94&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;687</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">73&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">74&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">71&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;496</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TAG (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;98</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;71</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;82</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;014</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum total cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;69</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;97</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;042</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum HDL-cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;46</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;64</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum LDL-cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;59</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;93</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;72</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;95</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;89</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;232</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;00</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;42</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;013</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum insulin (pmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">67&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">43&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">57&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">24&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">77&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">54&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;082</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum hs-CRP (mg/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;93</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;98</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;690</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>BP, blood pressure; hs-CRP, high-sensitive C-reactive protein.</p></fn></table-wrap-foot></table-wrap></p><p>Count of returned capsules indicated an almost full compliance of 98&#x000b7;2 (<sc>sd</sc> 2&#x000b7;6)
% and 98&#x000b7;0 (<sc>sd</sc> 4&#x000b7;1) % during quercetin and placebo consumption, respectively.
Compliance to quercetin supplementation was objectively confirmed by a marked increase in
plasma concentrations of quercetin and total flavonols by 1149&#x000b7;6 %
(<italic>P</italic>&#x0003c;0&#x000b7;0001) and 828&#x000b7;6 % (<italic>P</italic>&#x0003c;0&#x000b7;0001),
respectively (<xref ref-type="fig" rid="fig2">Fig. 2(a) and (b)</xref>). The increase was
measurable in all patients receiving quercetin. In addition, plasma concentrations of
kaempferol, isorhamnetin and tamarixetin significantly increased after quercetin but not
after placebo supplementation (data not shown). There was a high inter-individual
variation in plasma quercetin concentrations already at baseline (range for all study
subjects: 0&#x000b7;2&#x02013;330&#x000b7;5 nmol/l) and after quercetin supplementation (99&#x000b7;1&#x02013;1313&#x000b7;1 nmol/l).<fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Fasting plasma concentrations of quercetin (a) (<italic>n</italic> 68) and total
flavonols (b) (<italic>n</italic> 68) before and after the 6-week supplementation
with quercetin (162 mg/d; &#x025a0;) or placebo (&#x025a1;). Values are means and standard
deviations represented by vertical bars. *** Mean value was significantly different
from baseline (<italic>P</italic>&#x0003c;0&#x000b7;0001; intra-group comparison). &#x02020; Change
during quercetin treatment was significantly different from change during placebo
treatment (<italic>P</italic>&#x0003c;0&#x000b7;0001; inter-group comparison). Total plasma
flavonols were calculated as follows: total flavonols (nmol/l)=quercetin
(nmol/l)+kaempferol (nmol/l)+isorhamnetin (nmol/l)+tamarixetin (nmol/l). The two
groups did not differ significantly with regard to plasma concentrations of
quercetin and total flavonol at baseline (Wilcoxon signed-rank tests).</p></caption><graphic xlink:href="S0007114515002950_fig2"/></fig>
</p><p>Analyses of 3-d dietary records indicated no significant inter-group and intra-group
differences in mean daily intakes of energy, protein, carbohydrates, total fat, fatty
acids, cholesterol, antioxidants (e.g. vitamin E, vitamin C), dietary fibre and quercetin
(data not presented in Tables). Dietary quercetin intake was 11&#x000b7;3 (<sc>sd</sc> 11&#x000b7;9) mg/d
and 9&#x000b7;0 (<sc>sd</sc> 8&#x000b7;1) mg/d at the beginning and at the end of the quercetin treatment,
respectively, and 11&#x000b7;7 (<sc>sd</sc> 11&#x000b7;2) mg/d and 9&#x000b7;2 (<sc>sd</sc> 8&#x000b7;2) mg/d at the
beginning and at the end of the placebo treatment, respectively. Main dietary quercetin
sources were onions, apples and tea.</p></sec><sec id="sec2-2" sec-type="general"><title>Body weight, waist and hip circumference, body composition and potential side-effects</title><p>Quercetin supplementation did not significantly affect body weight, waist and hip
circumference, relative fat mass or fat-free mass (data not shown). Participants did not
report any side-effects, neither during quercetin nor during placebo treatment.</p></sec><sec id="sec2-3" sec-type="general"><title>Ambulatory blood pressure monitoring and office blood pressure</title><p>In the entire study group (<italic>n</italic> 68), quercetin and placebo supplements did
not significantly affect mean 24 h, day-time and night-time ABP parameters (SBP, DBP, MAP,
nocturnal dip in SBP and DBP). In addition, office BP (SBP and DBP, MAP) was not
significantly changed by quercetin or placebo treatment as analysed for the entire study
group (<xref ref-type="table" rid="tab3">Table 3</xref>). Resting SBP at baseline and the
change in SBP from baseline to after intervention were significantly correlated, with
those individuals with higher baseline SBP demonstrating greater reductions in SBP in
response to the quercetin treatment (<italic>r</italic> &#x02212;0&#x000b7;508,
<italic>P</italic>&#x0003c;0&#x000b7;0001; <italic>n</italic> 68). We also found a significant
interaction effect between stage of hypertension and treatment assignment for the
decreases in mean 24 h SBP (<italic>P</italic>=0&#x000b7;008) and in day-time SBP
(<italic>P</italic>=0&#x000b7;024) but not for the decrease in night-time SBP
(<italic>P</italic>=0&#x000b7;568) (data not shown). There were also significant interaction
effects between stage of hypertension and treatment assignment for decreases in mean 24 h
MAP (<italic>P</italic>=0&#x000b7;014) and in day-time MAP (<italic>P</italic>=0&#x000b7;032) but not for
decreases in night-time MAP (<italic>P</italic>=0&#x000b7;176) (data not shown). <table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Measurements of the 24 h ambulatory blood pressure and office blood pressure in the
total study group during the 6-week dietary supplementation with quercetin or
placebo<xref ref-type="fn" rid="tab3fn1">*</xref> (Mean values and standard
deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="7">Quercetin (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="8">Placebo (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> inter-group</th><th align="center" rowspan="1" colspan="2">Treatment difference</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">24 h ABP monitoring</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">133&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">132&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;329</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">132&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">132&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;848</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;460</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">82&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">81&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;304</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">81&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">80&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;425</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;711</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;227</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;520</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;977</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">74&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">76&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;003</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">74&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">75&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;372</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;189</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1"> Nocturnal dip in systolic BP (%)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;726</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;105</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;368</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1"> Nocturnal dip in diastolic BP (%)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">15&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;217</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;101</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;669</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1"> Day-time (06.00&#x02013;22.00 hours)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">136&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">135&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;347</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">135&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">136&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;440</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;172</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;2</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">85&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">84&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;457</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">84&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">84&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;932</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;538</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;9</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">102&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">101&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;315</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">101&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">101&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;640</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;257</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">76&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">78&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;006</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">76&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">77&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;367</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;202</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;4</td></tr><tr><td align="left" rowspan="1" colspan="1"> Night-time (22.00&#x02013;06.00 hours)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">121&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">120&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;322</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">120&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">119&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;238</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;921</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;0</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">71&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">70&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;106</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">70&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">69&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;085</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;946</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;9</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">88&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">87&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;093</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">88&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">86&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;139</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;911</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">66&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">69&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;004</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">67&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">68&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;459</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;203</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1"> Office BP</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">144&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">16&#x000b7;8</td><td align="left" rowspan="1" colspan="1">146&#x000b7;9</td><td align="left" rowspan="1" colspan="1">17&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;063</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">143&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">143&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;937</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;171</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+2&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">15&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1"> Diastolic BP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">98&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">97&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;338</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">97&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">96&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;166</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;863</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1"> MAP (mmHg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">113&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">113&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;879</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">112&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">112&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">12&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;361</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;472</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">11&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1"> Heart rate (beats per min)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">64&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">65&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;112</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">63&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">65&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;040</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;598</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;2</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>ABP, ambulatory blood pressure; BP, blood pressure; MAP, mean arterial
pressure.</p></fn><fn id="tab3fn1"><label>*</label><p>The two groups did not differ significantly with regard to any of the variables
at baseline (paired Student&#x02019;s <italic>t</italic> tests or Wilcoxon signed-rank
tests).</p></fn></table-wrap-foot></table-wrap></p><p>Effects of supplementation with quercetin or placebo on ABP profiles and office BP in the
subgroup of hypertensive patients are presented in <xref ref-type="table" rid="tab4">Table
4</xref>. Note that there are different n values for quercetin and placebo treatment
because the initial BP of the participants at the beginning of the quercetin and placebo
period slightly differed. In some cases, this physiological difference led to a different
BP classification. When compared with placebo (treatment difference, &#x02212;3&#x000b7;9 (<sc>sd</sc>
11&#x000b7;1) mmHg; <italic>P</italic>=0&#x000b7;049, <xref ref-type="table" rid="tab4">Table 4</xref>),
quercetin significantly decreased mean 24 h SBP by &#x02212;3&#x000b7;6 (<sc>sd</sc> 8&#x000b7;2) mmHg
(<italic>P</italic>=0&#x000b7;022) from baseline in the subgroup of stage 1 hypertensive subjects
(<italic>n</italic> 31). Changes in day-time SBP and night-time SBP during quercetin
treatment were not significantly different from placebo treatment. However, quercetin
significantly decreased day-time SBP by &#x02212;4&#x000b7;6 (<sc>sd</sc> 9&#x000b7;0) mmHg
(<italic>P</italic>=0&#x000b7;014) and night-time SBP by &#x02212;6&#x000b7;6 (<sc>sd</sc> 9&#x000b7;9) mmHg
(<italic>P</italic>=0&#x000b7;007) (<xref ref-type="table" rid="tab4">Table 4</xref>). In
addition, changes in 24 h MAP, day-time MAP and night-time MAP during quercetin did not
differ significantly from placebo. However, quercetin significantly reduced mean 24 h MAP,
day-time MAP and night-time MAP from baseline by &#x02212;2&#x000b7;8 (<sc>sd</sc> 7&#x000b7;3) mmHg
(<italic>P</italic>=0&#x000b7;043), by &#x02212;3&#x000b7;3 (<sc>sd</sc> 8&#x000b7;0) mmHg (<italic>P</italic>=0&#x000b7;042) and
by &#x02212;6&#x000b7;7 (<sc>sd</sc> 8&#x000b7;3) mmHg (<italic>P</italic>=0&#x000b7;001), respectively (<xref ref-type="table" rid="tab4">Table 4</xref>).</p><p>Treatment with quercetin did not significantly change the nocturnal dip in SBP and DBP.
In addition, systolic and diastolic office BP were not significantly changed by quercetin
or placebo treatment in hypertensive patients (<xref ref-type="table" rid="tab4">Table
4</xref>).</p></sec><sec id="sec2-4" sec-type="general"><title>Serum lipids, lipoproteins, apolipoproteins, glucose and insulin</title><p>No significant inter-group differences were found for the effects of quercetin or placebo
on serum lipids, lipoproteins, apolipoproteins, glucose and insulin. Furthermore,
quercetin supplementation did not significantly affect fasting serum total cholesterol,
LDL-cholesterol, HDL-cholesterol, TAG, apo B and A1, insulin, plasma glucose and
HbA<sub>1c</sub> neither in the total study group nor in the subgroup of hypertensive
patients (intra-group comparisons, <xref ref-type="table" rid="tab5">Table
5</xref>).<table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Fasting lipids, lipoproteins, apolipoproteins, insulin, glucose, HbA<sub>1c</sub>
and HOMA IR Index in the total study group (<italic>n</italic> 68) during the 6-week
dietary supplementation with quercetin or placebo<xref ref-type="fn" rid="tab5fn1">*</xref> (Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab5"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="7">Quercetin (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="8">Placebo (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value intra-group</th><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value intra-group</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value inter-group</th><th align="center" rowspan="1" colspan="2">Treatment difference</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Serum TAG (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;81</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;83</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;98</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;848</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;76</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;72</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;68</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;241</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;628</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;07</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;18</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum total cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;44</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;06</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;58</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;395</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;257</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;874</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;89</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum HDL-cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;39</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;238</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;00</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;929</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;406</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum LDL-cholesterol (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;90</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;43</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;459</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;95</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;88</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;008</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;193</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;10</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;63</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum apo B (g/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;257</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;233</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;864</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;00</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum apo A1 (g/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;128</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;62</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;240</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;824</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose (mmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;68</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;58</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;47</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;526</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;51</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;671</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;400</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;07</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum insulin (pmol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">47&#x000b7;82</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">33&#x000b7;62</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">46&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">35&#x000b7;86</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">24&#x000b7;48</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;649</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">51&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">38&#x000b7;75</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">46&#x000b7;39</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">38&#x000b7;85</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;4&#x000b7;75</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">26&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;079</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;197</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+3&#x000b7;53</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">39&#x000b7;16</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA IR index</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;57</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;51</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;92</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;911</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;72</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;42</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;41</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;99</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;071</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;226</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;41</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA<sub>1c</sub> (%)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;66</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;43</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;68</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;366</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;70</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;42</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;66</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;146</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;105</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>HOMA IR, homoeostasis model assessment of insulin resistance.</p></fn><fn id="tab5fn1"><label>*</label><p>The two groups did not differ significantly with regard to any of the variables
at baseline (paired Student&#x02019;s <italic>t</italic> tests or Wilcoxon signed-rank
tests).</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec2-5" sec-type="general"><title>Soluble adhesion molecules, asymmetric dimethylarginine, angiotensin-converting
enzyme, C-reactive protein, endothelial function and oxidation</title><p>For the total study group, quercetin supplementation did not significantly affect fasting
serum concentrations of endothelin-1, sE-selectin and sVCAM-1 (<xref ref-type="table" rid="tab6">Table 6</xref>). When compared with placebo, quercetin did not significantly
affect serum sICAM-1 (treatment difference, &#x02212;5&#x000b7;3 (<sc>sd</sc> 30&#x000b7;7) ng/ml,
<italic>P</italic>=0&#x000b7;219; <xref ref-type="table" rid="tab6">Table 6</xref>). However,
quercetin decreased fasting serum sICAM-1 from baseline by &#x02212;8&#x000b7;2 (<sc>sd</sc> 17&#x000b7;2) ng/ml
(intra-group comparison, <italic>P</italic>&#x0003c;0&#x000b7;001). Neither quercetin nor placebo
significantly altered fasting plasma concentrations of the endogenous NO synthase
inhibitor ADMA, the corresponding ratio of <sc>l</sc>-arginine to ADMA
(<sc>l</sc>-arginine:ADMA), serum ACE and serum CRP. Quercetin and placebo did not
significantly affect endothelial function (RHI and AI) (<xref ref-type="table" rid="tab6">Table 6</xref>). In addition, plasma oxLDL and urinary excretion of
8-iso-PGF2<italic>&#x003b1;</italic> and 2,3-dinor-15-F2t-IsoP were not significantly changed by
quercetin or placebo treatment in the total study group (<xref ref-type="table" rid="tab6">Table 6</xref>).<table-wrap id="tab6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Adhesion molecules, parameters of oxidation and inflammation and vascular testing
in the total study group (<italic>n</italic> 68) during the 6-week supplementation
with quercetin or placebo<xref ref-type="fn" rid="tab6fn1">*</xref> (Mean values and
standard deviations)</p></caption><alternatives><graphic xlink:href="S0007114515002950_tab6"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="7">Quercetin (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="8">Placebo (<italic>n</italic> 68)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="2">Baseline</th><th align="center" rowspan="1" colspan="2">Endpoint</th><th align="center" rowspan="1" colspan="2">Mean change</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> intra-group</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> inter-group</th><th align="center" rowspan="1" colspan="2">Treatment difference</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">comparison</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Serum endothelin-1 (pg/ml)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;74</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;74</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;46</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;639</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;78</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;014</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;129</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;71</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum sE-selektin (ng/ml)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">36&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">13&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">37&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">13&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;144</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">36&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">13&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">36&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;712</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;441</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum sVCAM-1 (ng/ml)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">581&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">161&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">571&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">143&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;9&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;444</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">572&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">152&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">595&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">155&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+22&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">99&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;063</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;055</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;32&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">135&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum sICAM-1 (ng/ml)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">205&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">54&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">197&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">48&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;8&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">202&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">53&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">199&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">51&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">26&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;378</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;219</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;5&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">30&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma oxLDL (ng/ml)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">408&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">348&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">406&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">300&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">202&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;859</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">371&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">236&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">386&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">221&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+15&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">114&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;342</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;352</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;17&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">235&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma ADMA (&#x000b5;mol/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;57</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;59</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;530</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;58</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;439</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;266</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td></tr><tr><td align="left" rowspan="1" colspan="1">
<sc>l</sc>-Arginine:ADMA-ratio</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">146&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">66&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">147&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">55&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">73&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;896</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">141&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">57&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">144&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">51&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+3&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">54&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;577</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;824</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;2&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">94&#x000b7;4</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum ACE (U/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">38&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">19&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">38&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">20&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;800</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">38&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">19&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">39&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">19&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;198</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;718</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;9</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum hs-CRP (mg/l)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;99</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;904</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;81</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;61</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;58</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;448</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;283</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;56</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;04</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary
8-iso-PGF2<italic>&#x003b1;</italic>/creatinine (pg/mg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">198&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">160&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">216&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">156&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+5&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">177&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;183</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">236&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">293&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">187&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">132&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;56&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">316&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;848</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;552</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02013;17&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">300&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary
2,3-dinor-15-F2t-IsoP/creatinine (pg/mg)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">644&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">342&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">645&#x000b7;7</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">393&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">257&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;608</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">664&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">396&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">669&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">370&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+4&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">259&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;788</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;984</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;1&#x000b7;0</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">390&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1">RHI (EndoPAT)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;90</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;60</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;89</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;56</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;911</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;57</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;88</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;48</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;66</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;650</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;762</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;69</td></tr><tr><td align="left" rowspan="1" colspan="1">AI (EndoPAT)<xref ref-type="fn" rid="tab6fn2">&#x02020;</xref>
</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">21&#x000b7;89</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">8&#x000b7;44</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">21&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;59</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;957</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">6&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">17&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">7&#x000b7;44</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">20&#x000b7;98</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">+0&#x000b7;81</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">10&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;578</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;733</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;71</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>ACE, angiotensin-converting enzyme; ADMA, asymmetric dimethylarginine; AI,
augmentation index; hs-CRP, high-sensitive C-reactive protein; IsoP, isoprostanes;
oxLDL, oxidised LDL; RHI, reactive hyperaemia index; sICAM-1, soluble
intercellular adhesion molecule 1; sVCAM-1, soluble vascular cell adhesion
molecule 1.</p></fn><fn id="tab6fn1"><label>*</label><p>The two groups did not differ significantly with regard to any of the variables
at baseline (paired Student&#x02019;s <italic>t</italic> tests or Wilcoxon signed-rank
tests). EndoPAT data were obtained in a subgroup of forty-eight participants.</p></fn><fn id="tab6fn2"><label>&#x02020;</label><p>Corrected for heart rate and normed to 75 bpm.</p></fn></table-wrap-foot></table-wrap>
</p><p>In the subgroup of hypertensive patients, neither quercetin nor placebo significantly
affected serum endothelin-1, sE-selectin, sVCAM-1, plasma ADMA, serum ACE and CRP (data
not in Tables). In addition, plasma oxLDL and urinary F2-IsoP were not significantly
changed by quercetin or placebo treatment in the subgroup of hypertensives (data not in
Tables). In the subgroup of hypertensive patients, quercetin and placebo significantly
decreased serum sICAM-1 concentrations from baseline to a similar extent (quercetin, &#x02212;9&#x000b7;3
(<sc>sd</sc> 14&#x000b7;8) ng/ml, <italic>P</italic>=0&#x000b7;002; placebo, &#x02212;8&#x000b7;6 (<sc>sd</sc> 15&#x000b7;9)
ng/ml, <italic>P</italic>=0&#x000b7;007; treatment difference, &#x02212;3&#x000b7;5 (<sc>sd</sc> 17&#x000b7;5) ng/ml,
<italic>P</italic>=0&#x000b7;584) (data not in Tables).</p></sec><sec id="sec2-6" sec-type="general"><title>Correlations between blood pressure and biomarkers of inflammation/endothelial
function</title><p>In the total study group and also in the subgroup of hypertensive patients, baseline SBP
and DBP did not significantly correlate with baseline biomarkers of inflammation and
endothelial function (CRP, endothelin-1, sE-selectin, sVCAM-1, sICAM-1, ADMA, RHI and AI).
In addition, changes in BP variables did not significantly correlate with changes in
biomarkers of inflammation and endothelial function, neither in the total study group nor
in the subgroup of hypertensives (data not shown).</p></sec></sec><sec sec-type="general" id="sec3"><title>Discussion</title><p>The aim of this double-blinded, placebo-controlled, cross-over intervention study was to
systematically investigate the effects of quercetin on arterial BP (primary variable),
endothelial function and further CVD risk markers in overweight-to-obese individuals with
hypertension. Our major finding was that quercetin supplementation for 6 weeks in a
supra-nutritional dosage significantly reduced 24 h systolic ABP in hypertensive
participants. In contrast to our hypotheses, we observed no effect of quercetin
supplementation on secondary variables such as endothelial function including RHI,
sE-selectin, sVCAM-1, ADMA and endothelin-1. In addition, no effects on parameters of
inflammation, oxidative stress and lipid and glucose metabolism were observed. We used a
moderate supra-nutritional but non-pharmacological dose of quercetin from onion skin
extract, as these data should provide a rational basis for the development of functional
foods.</p><sec id="sec3-1" sec-type="general"><title>Blood pressure</title><p>Quercetin significantly reduced the mean 24 h SBP by 3&#x000b7;6 (<sc>sd</sc> 8&#x000b7;2) mmHg in
hypertensive participants, but not in pre-hypertensive individuals, suggesting that a
threshold of elevated BP might be required to detect a BP-lowering effect of quercetin.
The significant interaction effect between stage of hypertension and treatment assignment
confirms this. In contrast to our previous trial<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>, we found no significant effects of chronic quercetin supplementation on
office SBP. At first glance, this finding is surprising. Our study design (e.g. quercetin
dose, intervention period) was similar to our earlier study. In addition, our participants
(pre-/hypertensive patients with abdominal fat distribution) and sample size were well
chosen in consideration with the primary objective of the trial. In accordance with our
previous study<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>, we observed a relatively high inter-individual variation in BP-lowering
effects of quercetin. In both studies, only 44 to 51 % of the participants showed a
decrease in systolic office BP, despite the fact that compliance with supplementation in
both trials was very high (94&#x02013;98 %). Compliance was confirmed by a marked increase in
plasma quercetin concentrations (final concentrations of both trials, 0&#x000b7;3&#x02013;0&#x000b7;45 &#x000b5;mol/l) and
also in the monomethylated derivatives isorhamnetin and tamarixetin. However, in both
trials, changes in BP were not significantly correlated with plasma total quercetin,
isorhamnetin and/or tamarixetin. These findings indicate that, in humans, the BP-lowering
effects of chronic quercetin supplementation are difficult to predict. In addition, it is
not possible to deduce a minimum plasma concentration or quercetin dose required for a
specific biological activity. In this regard, it is very likely that the plasma
concentration of total quercetin does not necessarily reflect the concentration at the
target sites. Similar high inter-individual variance in BP-lowering effects of quercetin
can be observed in the study of Edwards <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>)</sup> in human subjects treated with pharmacological doses of 730 mg/d quercetin
for 4 weeks. The authors illustrated individual subject responses during each
supplementation phase (placebo, quercetin) in their publication; however, they did not
discuss these results.</p><p>Overall, the quercetin-induced reductions in SBP observed in the present trial and
previously (range &#x02212;2&#x000b7;6 to &#x02212;8&#x000b7;8 mmHg)<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>,</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>,</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>,</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup> are similar to those experienced following current recommended lifestyle
modifications to reduce elevated BP (e.g. reducing sodium intake and body weight,
increasing physical activity)<sup>(</sup>
<xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref>
<sup>,</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup>. A 3&#x000b7;6 mmHg decrease in SBP as observed in the present trial would be
clinically meaningful when considered at the population level, particularly in view of the
large population of people with pre-hypertension and stage I hypertension<sup>(</sup>
<xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref>
<sup>)</sup>. In addition, similar effects have been found for other dietary flavonoids,
especially for flavonols from cocoa products<sup>(</sup>
<xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref>
<sup>,</sup>
<xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec3-2" sec-type="general"><title>Endothelial function, inflammation and oxidation</title><p>The first mechanism of action we explored was that quercetin-induced reductions in BP are
secondary to an improvement in vascular endothelial function. Rationale for this
hypotheses was based on data from (i) normotensive humans wherein acute administration of
200 mg quercetin increased plasma quercetin and NO metabolite concentrations while
decreasing endothelin-1<sup>(</sup>
<xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref>
<sup>)</sup>, (ii) hypertensive rats in which quercetin attenuated hypertension and/or
vascular dysfunction in a NO-dependent manner<sup>(</sup>
<xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref>
<sup>)</sup> and (iii) <italic>in vitro</italic> studies wherein quercetin decreased
cellular production of endothelin-1<sup>(</sup>
<xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref>
<sup>,</sup>
<xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref>
<sup>)</sup> and endothelial-derived adhesion molecules<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>)</sup>. In the present study, biomarkers of endothelial function (plasma
endothelin-1, sE-selectin, sVCAM-1, ADMA, RHI and AI) were unaffected by the quercetin
treatment. Therefore, these markers cannot explain a possible relationship between
quercetin and BP. However, in view of the only modest decrease in SBP, our study was
probably not suited to demonstrate small changes in these markers. In addition, baseline
PAT indices and endothelial-derived adhesion molecules did not correlate with BP,
emphasising that factors regulating endothelial function differ at least in part from
those regulating BP.</p><p>In contrast to previous <italic>in vitro</italic>
<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup> and <italic>in vivo</italic> results obtained in animal models<sup>(</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref>
<sup>)</sup> showing an anti-inflammatory effect of quercetin, quercetin supplementation
did not reduce serum concentrations of CRP. This may, in part, be explained by the
duration of the intervention and/or the quercetin dosage and/or the low-grade inflammatory
state of our participants, which were insufficient to elicit measurable effects. In
agreement with this finding and consistent with earlier studies in humans<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>,</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>,</sup>
<xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref>
<sup>)</sup>, no changes in biomarkers of <italic>in vivo</italic> lipid peroxidation
(plasma oxLDL and urinary IsoP) were observed following quercetin administration. This may
be attributed to an already sufficient antioxidant defence status of our hypertensive
subjects. All participants had an adequate dietary intake of essential antioxidants
(vitamins E, C, <italic>&#x003b2;</italic>-carotene). In addition, they did not report smoking or
excessive physical exercise.</p></sec><sec id="sec3-3" sec-type="general"><title>Angiotensin-converting enzyme</title><p>The second mechanism we hypothesised was that chronic quercetin supplementation decreased
arterial BP in hypertensive patients by decreasing ACE activity. Rationale for this
hypotheses was based on experimental studies demonstrating that quercetin inhibits ACE
<italic>in vitro</italic>
<sup>(</sup>
<xref rid="ref53" ref-type="bibr">
<sup>53</sup>
</xref>
<sup>)</sup> and on animal-based evidence showing a decrease in ACE activity after
quercetin treatment in rats<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>,</sup>
<xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref>
<sup>)</sup>. For example, Mackraj <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>)</sup> compared the long-term antihypertensive effects of captopril (ACE inhibitor)
with those of quercetin in Dahl salt-sensitive rats that were given daily injections of
captopril, quercetin or vehicle. Although BP increased in vehicle-treated Dahl rats, it
was significantly decreased compared with baseline in both quercetin- and
captopril-treated groups. The decrease in BP occurred in parallel with the down-regulation
of the angiotensin-I receptor in the kidney, increased urine volume and increased urinary
sodium excretion, thus providing a potential mechanism for the long-term BP-lowering
effects of quercetin<sup>(</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup>. However, although chronic quercetin administration decreased 24 h ABP in our
hypertensive patients, we found no decrease in plasma ACE activity. Our results are in
accordance with data recently reported by Larson <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref56" ref-type="bibr">
<sup>56</sup>
</xref>
<sup>)</sup> showing that acute, quercetin-induced reductions in BP in hypertensive
individuals were not secondary to a reduced ACE activity.</p></sec><sec id="sec3-4" sec-type="general"><title>Lipid and glucose metabolism</title><p>In the present study, chronic quercetin supplementation for 6 weeks did not affect
fasting serum concentrations of total cholesterol, LDL-cholesterol and HDL-cholesterol,
TAG and apolipoproteins, supporting previous data in metabolically healthy
participants<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>,</sup>
<xref rid="ref57" ref-type="bibr">
<sup>57</sup>
</xref>
<sup>)</sup>, in overweight-to-obese patients with metabolic syndrome traits<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>, in men with different apoE isoforms<sup>(</sup>
<xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref>
<sup>)</sup> and in women with type 2 diabetes mellitus<sup>(</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup>. In contrast, Lee <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref58" ref-type="bibr">
<sup>58</sup>
</xref>
<sup>)</sup> found that supplementation with quercetin (100 mg/d) for 10 weeks
significantly reduced fasting serum concentrations of total cholesterol and
LDL-cholesterol and significantly increased serum HDL-cholesterol in male smokers. In
addition, supplements of quercetin-rich red grape juice<sup>(</sup>
<xref rid="ref59" ref-type="bibr">
<sup>59</sup>
</xref>
<sup>)</sup> and grape powder<sup>(</sup>
<xref rid="ref60" ref-type="bibr">
<sup>60</sup>
</xref>
<sup>)</sup> favourably influenced plasma lipid profiles in human subjects. These
inconclusive results may be attributed to the duration of quercetin administration, the
baseline characteristics of the study participants and the dosage of the ingested
quercetin. Experimental studies in rat liver cells demonstrated that quercetin at high
concentrations (e.g. 25 &#x000b5;mol/l) may be involved in lipid metabolism by reducing hepatic
fatty acid, TAG and cholesterol synthesis<sup>(</sup>
<xref rid="ref61" ref-type="bibr">
<sup>61</sup>
</xref>
<sup>,</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>)</sup>.</p><p>In accordance with previous human studies<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>,</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>,</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>,</sup>
<xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref>
<sup>,</sup>
<xref rid="ref60" ref-type="bibr">
<sup>60</sup>
</xref>
<sup>)</sup>, quercetin did not affect fasting plasma glucose, serum insulin, HOMA IR or
HbA<sub>1c</sub> in our hypertensive patients, although Lee <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref58" ref-type="bibr">
<sup>58</sup>
</xref>
<sup>)</sup> demonstrated a slight decrease (&#x02212;3&#x000b7;9 %) in fasting serum glucose after
quercetin treatment. Our results are in contrast to experimental reports demonstrating the
hypoglycaemic effects of high quercetin doses (&#x02265;10 mg/kg of body weight) in animal models
(e.g. obese Zucker Rats)<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec3-5" sec-type="general"><title>Strengths and limitations</title><p>The major strengths of our study are the double-blinded placebo-controlled cross-over
design, the relatively large sample size, the high compliance to treatment, the low
dropout rate and the examination of numerous markers of vascular function. However, this
study also has a few potential limitations. First, we administered a quercetin-rich onion
skin extract instead of pure quercetin (quercetin dihydrate) as we did in our previous
trials<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>,</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>,</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup>. Onion skins are rich in quercetin aglycone<sup>(</sup>
<xref rid="ref63" ref-type="bibr">
<sup>63</sup>
</xref>
<sup>)</sup>, and the bioavailability of quercetin from capsules filled with onion skin
extract powder was shown to be significantly higher than that from capsules filled with
quercetin dihydrate (C Burak, V Br&#x000fc;ll, P Langguth, BF Zimmermann, B Stoffel-Wagner, P
Stehle, S Wolffram, S Egert, unpublished results). Thus, we decided to use a
quercetin-rich onion skin extract for the present trial. We characterised the polyphenol
spectrum of the extract (<xref ref-type="table" rid="tab1">Table 1</xref>), but we cannot
exclude that other unknown components in the onion skin extract may have influenced our
findings. Thus, strictly, the conclusion of our study is only true for quercetin-rich
onion skin extract but not for pure quercetin. Second, we conducted an explorative data
analysis. All parameters were analysed for the whole study group and also for the subgroup
of patients with hypertension. Due to the multiple test situations, we cannot fully
exclude that the significant effect on 24 h SBP in the subgroup of hypertensives was a
chance finding. On the other hand, we do not think that corrections for multiple testing
are meaningful in the context of explorative data analysis<sup>(</sup>
<xref rid="ref64" ref-type="bibr">
<sup>64</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec3-6" sec-type="general"><title>Conclusion</title><p>Regular ingestion of a supra-nutritional dose of 162 mg/d quercetin from onion skin
extract did not affect BP and endothelial function in the whole study population of
pre-hypertensive and stage 1 hypertensive overweight-to-obese subjects. In the subgroup of
hypertensives, quercetin was capable of decreasing 24 h SBP, suggesting a cardioprotective
effect of quercetin, but without effects on mechanistic parameters. Thus, the mechanisms
responsible for the BP-lowering effect of quercetin remain elusive.</p></sec></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>This study was supported by the German Research Foundation (S. E., grant no EG292/3-1). The
German Research Foundation had no role in the design, analysis or writing of this article.</p><p>V. B., P. S. and S. E. designed the study together with G. N. and C. M. who were the
medical advisors. V. B., C. B. and S. E. recruited the subjects and conducted the study. B.
A. performed the blinding procedure. P. L. prepared the capsules. V. B., C. B., B. S.-W., S.
W., S. N., B. F. Z. and S. E. participated in data collection and analysis. V. B., C. B. and
S. E. performed the statistical calculations with support from R. F.; V. B., P. S. and S. E.
wrote the manuscript. V.B. and S. E. had primary responsibility for the final content. All
authors read and approved the final manuscript.</p><p>There are no conflicts of interest.</p></ack><ref-list id="refs"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal">
<name><surname>Crozier</surname><given-names>A</given-names></name>, <name><surname>Jaganath</surname><given-names>IB</given-names></name> &#x00026; <name><surname>Clifford</surname><given-names>MN</given-names></name> (<year>2009</year>) <article-title>Dietary phenolics: chemistry, bioavailability
and effects on health</article-title>. <source>Nat Prod Rep</source>
<volume>26</volume>, <fpage>1001</fpage>&#x02013;<lpage>1043</lpage>.<pub-id pub-id-type="pmid">19636448</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal">
<name><surname>Erdman</surname><given-names>JW Jr</given-names></name>, <name><surname>Balentine</surname><given-names>D</given-names></name>, <name><surname>Arab</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Flavonoids and Heart
Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005,
Washington, DC</article-title>. <source>J Nutr</source>
<volume>137</volume>, <fpage>718S</fpage>&#x02013;<lpage>737S</lpage>.<pub-id pub-id-type="pmid">17311968</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal">
<name><surname>Scalbert</surname><given-names>A</given-names></name> &#x00026; <name><surname>Williamson</surname><given-names>G</given-names></name> (<year>2000</year>) <article-title>Dietary intake and bioavailability of
polyphenols</article-title>. <source>J Nutr</source>
<volume>130</volume>, <fpage>2073S</fpage>&#x02013;<lpage>2085S</lpage>.<pub-id pub-id-type="pmid">10917926</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Ouyang</surname><given-names>YY</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Flavonoid intake and risk
of CVD: a systematic review and meta-analysis of prospective cohort
studies</article-title>. <source>Br J Nutr</source>
<volume>111</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">23953879</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal">
<name><surname>Hubbard</surname><given-names>GP</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <name><surname>Lovegrove</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Ingestion of quercetin
inhibits platelet aggregation and essential components of the collagen-stimulated
platelet activation pathway in humans</article-title>. <source>J Thromb Haemost</source>
<volume>2</volume>, <fpage>2138</fpage>&#x02013;<lpage>2145</lpage>.<pub-id pub-id-type="pmid">15613018</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal">
<name><surname>Hubbard</surname><given-names>GP</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <name><surname>de Vos</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Ingestion of onion soup
high in quercetin inhibits platelet aggregation and essential components of the
collagen-stimulated platelet activation pathway in man: a pilot study</article-title>.
<source>Br J Nutr</source>
<volume>96</volume>, <fpage>482</fpage>&#x02013;<lpage>488</lpage>.<pub-id pub-id-type="pmid">16925853</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal">
<name><surname>Egert</surname><given-names>S</given-names></name>, <name><surname>Bosy-Westphal</surname><given-names>A</given-names></name>, <name><surname>Seiberl</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Quercetin reduces systolic
blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight
subjects with a high-cardiovascular disease risk phenotype: a double-blinded,
placebo-controlled cross-over study</article-title>. <source>Br J Nutr</source>
<volume>102</volume>, <fpage>1065</fpage>&#x02013;<lpage>1074</lpage>.<pub-id pub-id-type="pmid">19402938</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal">
<name><surname>Boots</surname><given-names>AW</given-names></name>, <name><surname>Wilms</surname><given-names>LC</given-names></name>, <name><surname>Swennen</surname><given-names>EL</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>
<italic>In vitro</italic> and <italic>ex vivo</italic> anti-inflammatory activity of
quercetin in healthy volunteers</article-title>. <source>Nutrition</source>
<volume>24</volume>, <fpage>703</fpage>&#x02013;<lpage>710</lpage>.<pub-id pub-id-type="pmid">18549926</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal">
<name><surname>Nair</surname><given-names>MP</given-names></name>, <name><surname>Mahajan</surname><given-names>S</given-names></name>, <name><surname>Reynolds</surname><given-names>JL</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The flavonoid quercetin
inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in
normal peripheral blood mononuclear cells via modulation of the NF-kappa beta
system</article-title>. <source>Clin Vaccine Immunol</source>
<volume>13</volume>, <fpage>319</fpage>&#x02013;<lpage>328</lpage>.<pub-id pub-id-type="pmid">16522772</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal">
<name><surname>Rivera</surname><given-names>L</given-names></name>, <name><surname>Moron</surname><given-names>R</given-names></name>, <name><surname>Sanchez</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Quercetin ameliorates
metabolic syndrome and improves the inflammatory status in obese zucker
rats</article-title>. <source>Obesity (Silver Spring)</source>
<volume>16</volume>, <fpage>2081</fpage>&#x02013;<lpage>2087</lpage>.<pub-id pub-id-type="pmid">18551111</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal">
<name><surname>Jeong</surname><given-names>SM</given-names></name>, <name><surname>Kang</surname><given-names>MJ</given-names></name>, <name><surname>Choi</surname><given-names>HN</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Quercetin ameliorates
hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db
mice</article-title>. <source>Nutr Res Pract</source>
<volume>6</volume>, <fpage>201</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">22808343</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal">
<name><surname>Kobori</surname><given-names>M</given-names></name>, <name><surname>Masumoto</surname><given-names>S</given-names></name>, <name><surname>Akimoto</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Chronic dietary intake of
quercetin alleviates hepatic fat accumulation associated with consumption of a
Western-style diet in C57/BL6J mice</article-title>. <source>Mol Nutr Food Res</source>
<volume>55</volume>, <fpage>530</fpage>&#x02013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">21462320</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal">
<name><surname>Edwards</surname><given-names>RL</given-names></name>, <name><surname>Lyon</surname><given-names>T</given-names></name>, <name><surname>Litwin</surname><given-names>SE</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Quercetin reduces blood
pressure in hypertensive subjects</article-title>. <source>J Nutr</source>
<volume>137</volume>, <fpage>2405</fpage>&#x02013;<lpage>2411</lpage>.<pub-id pub-id-type="pmid">17951477</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal">
<name><surname>Zahedi</surname><given-names>M</given-names></name>, <name><surname>Ghiasvand</surname><given-names>R</given-names></name>, <name><surname>Feizi</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Does quercetin improve
cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a
double-blind randomized controlled clinical trial</article-title>. <source>Int J Prev
Med</source>
<volume>4</volume>, <fpage>777</fpage>&#x02013;<lpage>785</lpage>.<pub-id pub-id-type="pmid">24049596</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal">
<name><surname>Larson</surname><given-names>AJ</given-names></name>, <name><surname>Symons</surname><given-names>JD</given-names></name> &#x00026; <name><surname>Jalili</surname><given-names>T</given-names></name> (<year>2012</year>) <article-title>Therapeutic potential of quercetin to decrease
blood pressure: review of efficacy and mechanisms</article-title>. <source>Adv Nutr</source>
<volume>3</volume>, <fpage>39</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">22332099</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal">
<name><surname>Zawadzki</surname><given-names>MJ</given-names></name>, <name><surname>Graham</surname><given-names>JW</given-names></name> &#x00026; <name><surname>Gerin</surname><given-names>W</given-names></name> (<year>2012</year>) <article-title>Increasing the validity and efficiency of blood
pressure estimates using ambulatory and clinic measurements and modern missing data
methods</article-title>. <source>Am J Hypertens</source>
<volume>25</volume>, <fpage>764</fpage>&#x02013;<lpage>769</lpage>.<pub-id pub-id-type="pmid">22513831</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal">
<name><surname>Myers</surname><given-names>MG</given-names></name> &#x00026; <name><surname>Godwin</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>Automated measurement of blood pressure in
routine clinical practice</article-title>. <source>J Clin Hypertens (Greenwich)</source>
<volume>9</volume>, <fpage>267</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">17396069</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal">
<name><surname>Chobanian</surname><given-names>AV</given-names></name>, <name><surname>Bakris</surname><given-names>GL</given-names></name>, <name><surname>Black</surname><given-names>HR</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>The Seventh Report of the
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure: the JNC 7 report</article-title>. <source>JAMA</source>
<volume>289</volume>, <fpage>2560</fpage>&#x02013;<lpage>2572</lpage>.<pub-id pub-id-type="pmid">12748199</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal">
<name><surname>Alberti</surname><given-names>KG</given-names></name>, <name><surname>Zimmet</surname><given-names>P</given-names></name> &#x00026; <name><surname>Shaw</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>The metabolic syndrome--a new worldwide
definition</article-title>. <source>Lancet</source>
<volume>366</volume>, <fpage>1059</fpage>&#x02013;<lpage>1062</lpage>.<pub-id pub-id-type="pmid">16182882</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal">
<name><surname>Linseisen</surname><given-names>J</given-names></name>, <name><surname>Radtke</surname><given-names>J</given-names></name> &#x00026; <name><surname>Wolfram</surname><given-names>G</given-names></name> (<year>1997</year>) <article-title>Flavonoid intake of adults in a Bavarian
subgroup of the national food consumption survey</article-title>. <source>Z
Ernahrungswiss</source>
<volume>36</volume>, <fpage>403</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="pmid">9467240</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal">
<name><surname>Zamora-Ros</surname><given-names>R</given-names></name>, <name><surname>Forouhi</surname><given-names>NG</given-names></name>, <name><surname>Sharp</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Dietary intakes of
individual flavanols and flavonols are inversely associated with incident type 2
diabetes in European populations</article-title>. <source>J Nutr</source>
<volume>144</volume>, <fpage>335</fpage>&#x02013;<lpage>343</lpage>.<pub-id pub-id-type="pmid">24368432</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal">
<name><surname>Egert</surname><given-names>S</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <name><surname>Schulze</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Enriched cereal bars are
more effective in increasing plasma quercetin compared with quercetin from powder-filled
hard capsules</article-title>. <source>Br J Nutr</source>
<volume>107</volume>, <fpage>539</fpage>&#x02013;<lpage>546</lpage>.<pub-id pub-id-type="pmid">21774840</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal">
<name><surname>Egert</surname><given-names>S</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <name><surname>Bosy-Westphal</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Daily quercetin
supplementation dose-dependently increases plasma quercetin concentrations in healthy
humans</article-title>. <source>J Nutr</source>
<volume>138</volume>, <fpage>1615</fpage>&#x02013;<lpage>1621</lpage>.<pub-id pub-id-type="pmid">18716159</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal">
<name><surname>Egert</surname><given-names>S</given-names></name>, <name><surname>Boesch-Saadatmandi</surname><given-names>C</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Serum lipid and blood
pressure responses to quercetin vary in overweight patients by apolipoprotein E
genotype</article-title>. <source>J Nutr</source>
<volume>140</volume>, <fpage>278</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">20032478</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal">
<name><surname>Pickering</surname><given-names>TG</given-names></name>, <name><surname>Hall</surname><given-names>JE</given-names></name>, <name><surname>Appel</surname><given-names>LJ</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Recommendations for blood
pressure measurement in humans and experimental animals: Part 1: blood pressure
measurement in humans: a statement for professionals from the Subcommittee of
Professional and Public Education of the American Heart Association Council on High
Blood Pressure Research</article-title>. <source>Hypertension</source>
<volume>45</volume>, <fpage>142</fpage>&#x02013;<lpage>161</lpage>.<pub-id pub-id-type="pmid">15611362</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="other">
<name><surname>Axtell</surname><given-names>AL</given-names></name>, <name><surname>Gomari</surname><given-names>FA</given-names></name> &#x00026; <name><surname>Cooke</surname><given-names>JP</given-names></name> (<year>2010</year>) Assessing endothelial vasodilator function with the Endo-PAT
2000. <italic>J Vis Exp</italic>, issue 44, 2167.</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal">
<name><surname>Kuvin</surname><given-names>JT</given-names></name>, <name><surname>Patel</surname><given-names>AR</given-names></name>, <name><surname>Sliney</surname><given-names>KA</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Assessment of peripheral
vascular endothelial function with finger arterial pulse wave amplitude</article-title>.
<source>Am Heart J</source>
<volume>146</volume>, <fpage>168</fpage>&#x02013;<lpage>174</lpage>.<pub-id pub-id-type="pmid">12851627</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal">
<name><surname>Nohria</surname><given-names>A</given-names></name>, <name><surname>Gerhard-Herman</surname><given-names>M</given-names></name>, <name><surname>Creager</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Role of nitric oxide in
the regulation of digital pulse volume amplitude in humans</article-title>. <source>J
Appl Physiol (1985)</source>
<volume>101</volume>, <fpage>545</fpage>&#x02013;<lpage>548</lpage>.<pub-id pub-id-type="pmid">16614356</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal">
<name><surname>Bonetti</surname><given-names>PO</given-names></name>, <name><surname>Pumper</surname><given-names>GM</given-names></name>, <name><surname>Higano</surname><given-names>ST</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Noninvasive identification
of patients with early coronary atherosclerosis by assessment of digital reactive
hyperemia</article-title>. <source>J Am Coll Cardiol</source>
<volume>44</volume>, <fpage>2137</fpage>&#x02013;<lpage>2141</lpage>.<pub-id pub-id-type="pmid">15582310</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal">
<name><surname>Hamburg</surname><given-names>NM</given-names></name>, <name><surname>Keyes</surname><given-names>MJ</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Cross-sectional relations
of digital vascular function to cardiovascular risk factors in the Framingham Heart
Study</article-title>. <source>Circulation</source>
<volume>117</volume>, <fpage>2467</fpage>&#x02013;<lpage>2474</lpage>.<pub-id pub-id-type="pmid">18458169</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal">
<name><surname>Sun</surname><given-names>SS</given-names></name>, <name><surname>Chumlea</surname><given-names>WC</given-names></name>, <name><surname>Heymsfield</surname><given-names>SB</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Development of
bioelectrical impedance analysis prediction equations for body composition with the use
of a multicomponent model for use in epidemiologic surveys</article-title>. <source>Am J
Clin Nutr</source>
<volume>77</volume>, <fpage>331</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">12540391</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal">
<name><surname>Matthews</surname><given-names>DR</given-names></name>, <name><surname>Hosker</surname><given-names>JP</given-names></name>, <name><surname>Rudenski</surname><given-names>AS</given-names></name>, <etal>et al</etal> (<year>1985</year>) <article-title>Homeostasis model
assessment: insulin resistance and beta-cell function from fasting plasma glucose and
insulin concentrations in man</article-title>. <source>Diabetologia</source>
<volume>28</volume>, <fpage>412</fpage>&#x02013;<lpage>419</lpage>.<pub-id pub-id-type="pmid">3899825</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal">
<name><surname>F&#x000fc;rst</surname><given-names>P</given-names></name>, <name><surname>Pollack</surname><given-names>L</given-names></name>, <name><surname>Graser</surname><given-names>TA</given-names></name>, <etal>et al</etal> (<year>1990</year>) <article-title>Appraisal of four
pre-column derivatization methods for the high-performance liquid chromatographic
determination of free amino acids in biological materials</article-title>. <source>J
Chromatogr</source>
<volume>499</volume>, <fpage>557</fpage>&#x02013;<lpage>569</lpage>.<pub-id pub-id-type="pmid">2324214</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal">
<name><surname>Bieger</surname><given-names>J</given-names></name>, <name><surname>Cermak</surname><given-names>R</given-names></name>, <name><surname>Blank</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Tissue distribution of
quercetin in pigs after long-term dietary supplementation</article-title>. <source>J
Nutr</source>
<volume>138</volume>, <fpage>1417</fpage>&#x02013;<lpage>1420</lpage>.<pub-id pub-id-type="pmid">18641184</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="other">
<collab>U.S.Department of Agriculture</collab> (<year>2013</year>) USDA database for the
flavonoid content of selected foods, release 3.1 <uri xlink:type="simple" xlink:href="http://wwwarsusdagov/Services/docshtm?docid=6231">http://www ars usda gov/Services/docs htm?docid=6231</uri>
</mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal">
<name><surname>Kenward</surname><given-names>MG</given-names></name> &#x00026; <name><surname>Jones</surname><given-names>B</given-names></name> (<year>1987</year>) <article-title>The analysis of data from 2&#x000d7;2 cross-over trials
with baseline measurements</article-title>. <source>Stat Med</source>
<volume>6</volume>, <fpage>911</fpage>&#x02013;<lpage>926</lpage>.<pub-id pub-id-type="pmid">3438617</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal">
<name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Brands</surname><given-names>MW</given-names></name>, <name><surname>Daniels</surname><given-names>SR</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Dietary approaches to
prevent and treat hypertension: a scientific statement from the American Heart
Association</article-title>. <source>Hypertension</source>
<volume>47</volume>, <fpage>296</fpage>&#x02013;<lpage>308</lpage>.<pub-id pub-id-type="pmid">16434724</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal">
<name><surname>Whelton</surname><given-names>PK</given-names></name>, <name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Sacco</surname><given-names>RL</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Sodium, blood pressure,
and cardiovascular disease: further evidence supporting the American Heart Association
sodium reduction recommendations</article-title>. <source>Circulation</source>
<volume>126</volume>, <fpage>2880</fpage>&#x02013;<lpage>2889</lpage>.<pub-id pub-id-type="pmid">23124030</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal">
<name><surname>Lewington</surname><given-names>S</given-names></name>, <name><surname>Clarke</surname><given-names>R</given-names></name>, <name><surname>Qizilbash</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Age-specific relevance of
usual blood pressure to vascular mortality: a meta-analysis of individual data for one
million adults in 61 prospective studies</article-title>. <source>Lancet</source>
<volume>360</volume>, <fpage>1903</fpage>&#x02013;<lpage>1913</lpage>.<pub-id pub-id-type="pmid">12493255</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal">
<name><surname>Ellinger</surname><given-names>S</given-names></name>, <name><surname>Reusch</surname><given-names>A</given-names></name>, <name><surname>Stehle</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Epicatechin ingested via
cocoa products reduces blood pressure in humans: a nonlinear regression model with a
Bayesian approach</article-title>. <source>Am J Clin Nutr</source>
<volume>95</volume>, <fpage>1365</fpage>&#x02013;<lpage>1377</lpage>.<pub-id pub-id-type="pmid">22552030</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal">
<name><surname>Hooper</surname><given-names>L</given-names></name>, <name><surname>Kay</surname><given-names>C</given-names></name>, <name><surname>Abdelhamid</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effects of chocolate,
cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis
of randomized trials</article-title>. <source>Am J Clin Nutr</source>
<volume>95</volume>, <fpage>740</fpage>&#x02013;<lpage>751</lpage>.<pub-id pub-id-type="pmid">22301923</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal">
<name><surname>Loke</surname><given-names>WM</given-names></name>, <name><surname>Hodgson</surname><given-names>JM</given-names></name>, <name><surname>Proudfoot</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Pure dietary flavonoids
quercetin and (&#x02212;)-epicatechin augment nitric oxide products and reduce endothelin-1
acutely in healthy men</article-title>. <source>Am J Clin Nutr</source>
<volume>88</volume>, <fpage>1018</fpage>&#x02013;<lpage>1025</lpage>.<pub-id pub-id-type="pmid">18842789</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal">
<name><surname>Duarte</surname><given-names>J</given-names></name>, <name><surname>Jimenez</surname><given-names>R</given-names></name>, <name><surname>O&#x02019;Valle</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Protective effects of the
flavonoid quercetin in chronic nitric oxide deficient rats</article-title>. <source>J
Hypertens</source>
<volume>20</volume>, <fpage>1843</fpage>&#x02013;<lpage>1854</lpage>.<pub-id pub-id-type="pmid">12195128</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal">
<name><surname>Galindo</surname><given-names>P</given-names></name>, <name><surname>Rodriguez-Gomez</surname><given-names>I</given-names></name>, <name><surname>Gonzalez-Manzano</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Glucuronidated quercetin
lowers blood pressure in spontaneously hypertensive rats via
deconjugation</article-title>. <source>PLOS ONE</source>
<volume>7</volume>, <fpage>e32673</fpage>.<pub-id pub-id-type="pmid">22427863</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal">
<name><surname>Sanchez</surname><given-names>M</given-names></name>, <name><surname>Galisteo</surname><given-names>M</given-names></name>, <name><surname>Vera</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Quercetin downregulates
NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in
spontaneously hypertensive rats</article-title>. <source>J Hypertens</source>
<volume>24</volume>, <fpage>75</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">16331104</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal">
<name><surname>Ruef</surname><given-names>J</given-names></name>, <name><surname>Moser</surname><given-names>M</given-names></name>, <name><surname>Kubler</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Induction of endothelin-1
expression by oxidative stress in vascular smooth muscle cells</article-title>.
<source>Cardiovasc Pathol</source>
<volume>10</volume>, <fpage>311</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="pmid">11755377</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal">
<name><surname>Zhao</surname><given-names>X</given-names></name>, <name><surname>Gu</surname><given-names>Z</given-names></name>, <name><surname>Attele</surname><given-names>AS</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Effects of quercetin on
the release of endothelin, prostacyclin and tissue plasminogen activator from human
endothelial cells in culture</article-title>. <source>J Ethnopharmacol</source>
<volume>67</volume>, <fpage>279</fpage>&#x02013;<lpage>285</lpage>.<pub-id pub-id-type="pmid">10617062</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal">
<name><surname>Ying</surname><given-names>B</given-names></name>, <name><surname>Yang</surname><given-names>T</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Quercetin inhibits IL-1
beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK
pathways</article-title>. <source>Mol Biol Rep</source>
<volume>36</volume>, <fpage>1825</fpage>&#x02013;<lpage>1832</lpage>.<pub-id pub-id-type="pmid">18982426</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal">
<name><surname>Kleemann</surname><given-names>R</given-names></name>, <name><surname>Verschuren</surname><given-names>L</given-names></name>, <name><surname>Morrison</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Anti-inflammatory,
anti-proliferative and anti-atherosclerotic effects of quercetin in human <italic>in
vitro</italic> and <italic>in vivo</italic> models</article-title>.
<source>Atherosclerosis</source>
<volume>218</volume>, <fpage>44</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">21601209</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal">
<name><surname>Boesch-Saadatmandi</surname><given-names>C</given-names></name>, <name><surname>Wagner</surname><given-names>AE</given-names></name>, <name><surname>Wolffram</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effect of quercetin on
inflammatory gene expression in mice liver <italic>in vivo</italic> - role of redox
factor 1, miRNA-122 and miRNA-125b</article-title>. <source>Pharmacol Res</source>
<volume>65</volume>, <fpage>523</fpage>&#x02013;<lpage>530</lpage>.<pub-id pub-id-type="pmid">22402395</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal">
<name><surname>Mahmoud</surname><given-names>MF</given-names></name>, <name><surname>Hassan</surname><given-names>NA</given-names></name>, <name><surname>El Bassossy</surname><given-names>HM</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Quercetin protects against
diabetes-induced exaggerated vasoconstriction in rats: effect on low grade
inflammation</article-title>. <source>PLOS ONE</source>
<volume>8</volume>, <fpage>e63784</fpage>.<pub-id pub-id-type="pmid">23717483</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal">
<name><surname>Pfeuffer</surname><given-names>MA</given-names></name>, <name><surname>Auinger</surname><given-names>A</given-names></name>, <name><surname>Bley</surname><given-names>U</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Effect of quercetin on
traits of the metabolic syndrome, endothelial function and inflammatory parameters in
men with different APOE isoforms</article-title>. <source>Nutr Metab Cardiovasc Dis</source>
<volume>23</volume>, <fpage>403</fpage>&#x02013;<lpage>409</lpage>.<pub-id pub-id-type="pmid">22118955</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal">
<name><surname>Loizzo</surname><given-names>MR</given-names></name>, <name><surname>Said</surname><given-names>A</given-names></name>, <name><surname>Tundis</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Inhibition of angiotensin
converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb)
(Simaroubaceae)</article-title>. <source>Phytother Res</source>
<volume>21</volume>, <fpage>32</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">17072829</pub-id></mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal">
<name><surname>Mackraj</surname><given-names>I</given-names></name>, <name><surname>Govender</surname><given-names>T</given-names></name> &#x00026; <name><surname>Ramesar</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>The antihypertensive effects of quercetin in a
salt-sensitive model of hypertension</article-title>. <source>J Cardiovasc Pharmacol</source>
<volume>51</volume>, <fpage>239</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">18356687</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal">
<name><surname>Hackl</surname><given-names>LP</given-names></name>, <name><surname>Cuttle</surname><given-names>G</given-names></name>, <name><surname>Dovichi</surname><given-names>SS</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Inhibition of
angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin
and angiotensin I</article-title>. <source>Pharmacology</source>
<volume>65</volume>, <fpage>182</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">12174832</pub-id></mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal">
<name><surname>Larson</surname><given-names>A</given-names></name>, <name><surname>Witman</surname><given-names>MA</given-names></name>, <name><surname>Guo</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Acute, quercetin-induced
reductions in blood pressure in hypertensive individuals are not secondary to lower
plasma angiotensin-converting enzyme activity or endothelin-1: nitric
oxide</article-title>. <source>Nutr Res</source>
<volume>32</volume>, <fpage>557</fpage>&#x02013;<lpage>564</lpage>.<pub-id pub-id-type="pmid">22935338</pub-id></mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal">
<name><surname>Conquer</surname><given-names>JA</given-names></name>, <name><surname>Maiani</surname><given-names>G</given-names></name>, <name><surname>Azzini</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Supplementation with
quercetin markedly increases plasma quercetin concentration without effect on selected
risk factors for heart disease in healthy subjects</article-title>. <source>J Nutr</source>
<volume>128</volume>, <fpage>593</fpage>&#x02013;<lpage>597</lpage>.<pub-id pub-id-type="pmid">9482769</pub-id></mixed-citation></ref><ref id="ref58"><label>58.</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>KH</given-names></name>, <name><surname>Park</surname><given-names>E</given-names></name>, <name><surname>Lee</surname><given-names>HJ</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Effects of daily
quercetin-rich supplementation on cardiometabolic risks in male smokers</article-title>.
<source>Nutr Res Pract</source>
<volume>5</volume>, <fpage>28</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">21487493</pub-id></mixed-citation></ref><ref id="ref59"><label>59.</label><mixed-citation publication-type="journal">
<name><surname>Castilla</surname><given-names>P</given-names></name>, <name><surname>Echarri</surname><given-names>R</given-names></name>, <name><surname>Davalos</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Concentrated red grape
juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both
hemodialysis patients and healthy subjects</article-title>. <source>Am J Clin Nutr</source>
<volume>84</volume>, <fpage>252</fpage>&#x02013;<lpage>262</lpage>.<pub-id pub-id-type="pmid">16825703</pub-id></mixed-citation></ref><ref id="ref60"><label>60.</label><mixed-citation publication-type="journal">
<name><surname>Zern</surname><given-names>TL</given-names></name>, <name><surname>Wood</surname><given-names>RJ</given-names></name>, <name><surname>Greene</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Grape polyphenols exert a
cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and
reducing oxidative stress</article-title>. <source>J Nutr</source>
<volume>135</volume>, <fpage>1911</fpage>&#x02013;<lpage>1917</lpage>.<pub-id pub-id-type="pmid">16046716</pub-id></mixed-citation></ref><ref id="ref61"><label>61.</label><mixed-citation publication-type="journal">
<name><surname>Gnoni</surname><given-names>GV</given-names></name>, <name><surname>Paglialonga</surname><given-names>G</given-names></name> &#x00026; <name><surname>Siculella</surname><given-names>L</given-names></name> (<year>2009</year>) <article-title>Quercetin inhibits fatty acid and TAG synthesis
in rat-liver cells</article-title>. <source>Eur J Clin Invest</source>
<volume>39</volume>, <fpage>761</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">19508303</pub-id></mixed-citation></ref><ref id="ref62"><label>62.</label><mixed-citation publication-type="journal">
<name><surname>Glasser</surname><given-names>G</given-names></name>, <name><surname>Graefe</surname><given-names>EU</given-names></name>, <name><surname>Struck</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Comparison of
antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin
and potential metabolites</article-title>. <source>Phytomedicine</source>
<volume>9</volume>, <fpage>33</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">11924762</pub-id></mixed-citation></ref><ref id="ref63"><label>63.</label><mixed-citation publication-type="journal">
<name><surname>Wiczkowski</surname><given-names>W</given-names></name>, <name><surname>Romaszko</surname><given-names>J</given-names></name>, <name><surname>Bucinski</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Quercetin from shallots
(<italic>Allium cepa</italic> L. var. aggregatum) is more bioavailable than its
glucosides</article-title>. <source>J Nutr</source>
<volume>138</volume>, <fpage>885</fpage>&#x02013;<lpage>888</lpage>.<pub-id pub-id-type="pmid">18424596</pub-id></mixed-citation></ref><ref id="ref64"><label>64.</label><mixed-citation publication-type="journal">
<name><surname>Rothman</surname><given-names>KJ</given-names></name> (<year>1990</year>) <article-title>No adjustments are needed for multiple
comparisons</article-title>. <source>Epidemiology</source>
<volume>1</volume>, <fpage>43</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">2081237</pub-id></mixed-citation></ref></ref-list></back></article>